APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b

• DOI: 10.1007/s00018-022-04443-7
• Publication Date: 2022-07-25T10:02:44Z
• Authors: Giulia Antoniali; Emiliano Dalla; Giovanna Mangiapane; Xiaolong Zhao; Xinming Jing; Yi Cheng; Veronica De Sanctis; Dilara Ayyildiz; Silvano Piazza; Mengxia Li; Gianluca Tell
• Keywords: Ribonuclease III; 0301 basic medicine; Lung Neoplasms; Down-Regulation; 3. Good health; DEAD-box RNA Helicases; Gene Expression Regulation, Neoplastic; MicroRNAs; 03 medical and health sciences; Cancer; Gene signatures; Network analysis; miRnome; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Original Article

AbstractIncreasing evidence suggests different, not completely understood roles of microRNA biogenesis in the development and progression of lung cancer. The overexpression of the DNA repair protein apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is an important cause of poor chemotherapeutic response in lung cancer and its involvement in onco-miRNAs biogenesis has been recently described. Whether APE1 regulates miRNAs acting as prognostic biomarkers of lung cancer has not been investigated, yet. In this study, we analyzed miRNAs differential expression upon APE1 depletion in the A549 lung cancer cell line using high-throughput methods. We defined a signature of 13 miRNAs that strongly correlate with APE1 expression in human lung cancer: miR-1246, miR-4488, miR-24, miR-183, miR-660, miR-130b, miR-543, miR-200c, miR-376c, miR-218, miR-146a, miR-92b and miR-33a. Functional enrichment analysis of this signature revealed its biological relevance in cancer cell proliferation and survival. We validated DICER1 as a direct functional target of the APE1-regulated miRNA-33a-5p and miR-130b-3p. Importantly, IHC analyses of different human tumors confirmed a negative correlation existing between APE1 and Dicer1 protein levels. DICER1 downregulation represents a prognostic marker of cancer development but the mechanisms at the basis of this phenomenon are still completely unknown. Our findings, suggesting that APE1 modulates DICER1 expression via miR-33a and miR-130b, reveal new mechanistic insights on DICER1 regulation, which are of relevance in lung cancer chemoresistance and cancer invasiveness.